Low-dose computed tomography (LDCT) screening for lung cancer substantially reduces
mortality from lung cancer, as revealed in randomized controlled trials and meta-analyses …

Summary In this Policy Review we discuss ten key pressure points in the NHS in the delivery
of cancer care services that need to be urgently addressed by a comprehensive national …

Brain metastatic cancer poses a significant clinical challenge, with limited treatment options
and poor prognosis for patients. In recent years, immunotherapy has emerged as a …

Objectives To examine the accuracy and impact of artificial intelligence (AI) software
assistance in lung cancer screening using CT. Methods A systematic review of CE-marked …

Background Lung cancer screening programs concern smokers at risk for cardiovascular
diseases (CVDs) and chronic obstructive pulmonary disease (COPD). The LUMASCAN …

Lung cancer screening (LCS) programmes have emerged over recent years around the
world. LCS programmes present differences in delivery, inclusion criteria and resource …

Background The cost-effectiveness of different lung cancer screening strategies has been
evaluated from an Australian public health system perspective using static models. In …

Lung cancer screening programs, particularly in the UK, have shown a decrease in lung
cancer-related deaths among individuals who underwent low-dose computed tomography …

Introduction Lung cancer screening (LCS) trials, targeting people with a smoking history,
have demonstrated reduced mortality. How to optimally embed evidence-based smoking …

Lung cancer is the leading cause of cancer-related deaths worldwide, and delayed
detection contributes to poor outcomes. Primary care plays a crucial role in early diagnosis …